Trends & Forecasts

Jason Bock highlights the need for innovative manufacturing solutions and supply chain improvements in cell therapy.

Technological advances are opening up new drug development opportunities for rare diseases.

The increasing focus on sustainability in the pharmaceutical industry amongst CDMOs reveals the key strategies and initiatives being undertaken.

Counterfeit medicines pose a significant threat to global health. A recent study uncovers alarming facts and emphasizes the need for solutions.

Delali Attipoe at the DNDi explains why we need an R&D model attuned to the needs of forgotten patients.

What does the future hold for pharma? Audrey Greenberg and Jon Zwinski give their views.

As part of our 10-year anniversary special feature, Markus Kosch tells us his views on the future of pharma.

What trends and disruptions will shape the future of pharma? West’s Anya Harry gives her view.

Anna Codina from Bruker BioSpin discusses the Biosecure Act and how outsourcing could be affected.

The highlights of the trade show and its conference agenda - day 3